A new Michigan bill titled SB-1055 would require healthcare officials to obtain informed consent before administering vaccines with “aborted fetal tissues.”



The bill states, “The department shall create and maintain a list of each immunizing agent derived from aborted fetal tissue. If an immunizing agent that is not an immunizing agent derived from aborted fetal tissue is available in an alternative to an immunizing agent derived from aborted fetal tissue, the department shall include the alternative on the list.”



The Bill proposes the department shall maintain and update a list annually which will be available to the public on the department’s website. The list will designate vaccines developed using stem cells from the tissue of aborted babies.



Under the bill, a healthcare provider would be required to notify patients before administering a vaccine if the immunizing agent was derived from aborted fetal tissue and to offer alternative vaccines which were not derived from aborted fetal tissue if available. An immunizing agent derived from aborted fetal tissue is manufactured using a human fetal or embryonic cell line, protein, deoxyribonucleic antibody, or any other component derived from an elective abortion using a cell line derived from the tissue of a fetus which was electively aborted.



Right to Life Michigan President Barbara Listing said, “The existence of these vaccines requires patients and parents to make important ethical decisions. Sadly, many people are unaware of these facts, including many doctors and nurses. Patients need accurate information to make informed decisions, and many are not getting that now.”



Common arguments proposed against this bill include the fact no new cells are acquired for the purpose of making these vaccines. Opponents of the bill argue the child was not intentionally aborted in order to use the fetal tissue for vaccination purposes.



Pro-abortion advocates argue the residual amounts of DNA contained in these vaccines are too minute to have any detectable effect on health. They claim the PCR amplification is barely able to detect the low levels of DNA which proscribes pro-lifers from representing this as “injecting fetal cells” into the vaccine.



Not only would it be nearly impossible to maintain a controlled environment in which the effects of aborted fetal tissue on health could be measured, but a threshold for the amount of aborted fetal tissue exposure would also need to be established. Establishing the threshold of aborted fetal tissue’s impact on health is important in establishing its toxicity. However, pro-life advocates argue the main concern is not the impact on an individual’s health, but rather the ethics of using aborted fetal tissue to act as an immunizing agent.



Though pregnancies may not be terminated for the expressed purpose of using fetal tissue as immunizing agents in vaccinations, the effectiveness of vaccinations containing aborted fetal tissue drives the demand for more aborted fetal tissue. In turn, the demand for aborted fetal tissue drives an increasing reliance on abortion to be used as an immunizing agent. Essentially, if abortions ceased, those who prepare these specific vaccines derived would not be able to use aborted fetal tissue due to the diminishing supply.

Read more about the link between vaccines, abortion & fetal tissue here.



